UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

A Controlled Trial of Renal Denervation for Resistant Hypertension

The New England journal of medicine, 2014-04, Vol.370 (15), p.1393-1401

2014

Volltextzugriff (PDF)

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (16), p.1735

2016

Volltextzugriff (PDF)

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

The New England journal of medicine, 2014-12, Vol.371 (23), p.2155-2166

2014

Volltextzugriff (PDF)

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.2213-2223

2017

Volltextzugriff (PDF)

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography

JAMA : the journal of the American Medical Association, 2012-09, Vol.308 (12), p.1237

2012

Volltextzugriff (PDF)

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Journal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221

2015

Volltextzugriff (PDF)

Stent thrombosis in randomized clinical trials of drug-eluting stents

The New England journal of medicine, 2007-03, Vol.356 (10), p.1020-1029

2007

Volltextzugriff (PDF)

Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After MitraClip Therapy

Circulation (New York, N.Y.), 2013-10, Vol.128 (15), p.1667-1674

2013

Volltextzugriff (PDF)

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs

The American heart journal, 2018-01, Vol.195, p.115-129

2018

Volltextzugriff (PDF)

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

Journal of the American College of Cardiology, 2016-05, Vol.67 (21), p.2492-2502

2016

Volltextzugriff (PDF)

Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction

The New England journal of medicine, 2008-09, Vol.359 (13), p.1330-1342

2008

Volltextzugriff (PDF)

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1396-1405

2012

Volltextzugriff (PDF)

Dual Antiplatelet Therapy Duration Following Coronary Stenting

Journal of the American College of Cardiology, 2015-03, Vol.65 (8), p.787-790

2015

Volltextzugriff (PDF)

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

The American heart journal, 2010-12, Vol.160 (6), p.1035-1041.e1

2010

Volltextzugriff (PDF)

Coronary artery spatial distribution of acute myocardial infarction occlusions

Circulation (New York, N.Y.), 2004-07, Vol.110 (3), p.278-284

2004

Volltextzugriff (PDF)

Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts

Circulation (New York, N.Y.), 2008-10, Vol.118 (18), p.1817-1827

2008

Volltextzugriff (PDF)

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

The American journal of cardiology, 2015-09, Vol.116 (5), p.686-693

2015

Volltextzugriff (PDF)

Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients

Stroke (1970), 2012-12, Vol.43 (12), p.3218-3224

2012

Volltextzugriff (PDF)

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

The American heart journal, 2015-02, Vol.169 (2), p.222-233.e5

2015

Volltextzugriff (PDF)

Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)

The American journal of cardiology, 2015-06, Vol.115 (12), p.1678-1684

2015

Volltextzugriff (PDF)

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression

Nature communications, 2018-05, Vol.9 (1), p.1787-12, Article 1787

2018

Volltextzugriff (PDF)

Thrombotic Complications Associated With Early and Late Nonadherence to Dual Antiplatelet Therapy

JACC. Cardiovascular interventions, 2015-03, Vol.8 (3), p.404-410

2015

Volltextzugriff (PDF)

Distribution of Coronary Artery Disease and Relation to Mortality in Asymptomatic Hemodialysis Patients

American journal of kidney diseases, 2007-03, Vol.49 (3), p.409-416

2007

Volltextzugriff (PDF)

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents

JACC. Cardiovascular interventions, 2016-01, Vol.9 (2), p.138-147

2016

Volltextzugriff (PDF)

Effects of Atrial Fibrillation on Treatment of Mitral Regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) Randomized Trial

Journal of the American College of Cardiology, 2012-04, Vol.59 (14), p.1312-1319

2012

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(230)
magazinearticle
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(228)
Female
(219)
Science & Technology
(216)
Life Sciences & Biomedicine
(213)
Middle Aged
(166)
Aged
(138)
Cardiovascular System & Cardiology
(125)
Cardiac & Cardiovascular Systems
(121)
Treatment Outcome
(101)
Time Factors
(68)
Stents
(65)
Adult
(60)
Biological And Medical Sciences
(60)
Medical Sciences
(60)
Risk Factors
(59)
Drug-Eluting Stents
(57)
Prospective Studies
(48)
Follow-Up Studies
(42)
Heart Attacks
(38)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Controlled Trial of Renal Denervation for Resistant Hypertension

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Stent thrombosis in randomized clinical trials of drug-eluting stents

Relationship Between the Magnitude of Reduction in Mitral Regurgitation Severity and Left Ventricular and Left Atrial Reverse Remodeling After MitraClip Therapy

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

Dual Antiplatelet Therapy Duration Following Coronary Stenting

Coronary artery spatial distribution of acute myocardial infarction occlusions

Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression

Thrombotic Complications Associated With Early and Late Nonadherence to Dual Antiplatelet Therapy

Distribution of Coronary Artery Disease and Relation to Mortality in Asymptomatic Hemodialysis Patients

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents

Effects of Atrial Fibrillation on Treatment of Mitral Regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) Randomized Trial

Aktive Filter

Suchergebnisse filtern